Literature DB >> 30597420

Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.

Tino Prell1, Nayana Gaur2, Beatrice Stubendorff2, Annekathrin Rödiger2, Otto W Witte3, Julian Grosskreutz3.   

Abstract

OBJECTIVES: To determine the impact of disease progression on health-related quality of life in amyotrophic lateral sclerosis (ALS).
METHODS: A total of 161 patients with ALS were enrolled. Assessments included the revised ALS Functional Rating Scale and the ALS Assessment Questionnaire (ALSAQ-40). Data analysis comprised linear regression and multivariate analyses.
RESULTS: ALSFRS-R score (β = 0.75, p < 0.001), depression (β = 0.08, p < 0.001), pain (β = 0.07, p < 0.001), hopelessness (β = 0.07, p = 0.001), and progression rate (β = 0.02, p = 0.02) explained 76% of the ALSAQ-40 summary index variance. Progression rate alone explained 7% of the ALSAQ-40 summary index variance. The subdomains of emotional well-being, followed by ADL, and finally communication and eating were most strongly influenced by progression rate.
CONCLUSION: Our study demonstrates the importance of physical health for emotional well-being. In particular, slower disease progression is associated with higher levels of emotional well-being in ALS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALS Assessment Questionnaire 40; Depression; Disease progression; Emotional well-being; Health-related quality of life

Mesh:

Year:  2018        PMID: 30597420     DOI: 10.1016/j.jns.2018.12.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis.

Authors:  Takehisa Hirayama; Mari Shibukawa; Masaru Yanagihashi; Hitoshi Warita; Naoki Atsuta; Koji Yamanaka; Osamu Kano
Journal:  Acta Neurol Belg       Date:  2022-08-20       Impact factor: 2.471

2.  Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.

Authors:  Qian-Qian Wei; Yanbing Hou; Yongping Chen; Ruwei Ou; Bei Cao; Lingyu Zhang; Tianmi Yang; Huifang Shang
Journal:  Health Qual Life Outcomes       Date:  2021-07-20       Impact factor: 3.186

3.  Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage.

Authors:  Emma M Devenney; Kate McErlean; Nga Yan Tse; Jashelle Caga; Thanuja Dharmadasa; William Huynh; Colin J Mahoney; Margaret Zoing; Srestha Mazumder; Carol Dobson-Stone; John B Kwok; Glenda M Halliday; John R Hodges; Olivier Piguet; Rebekah M Ahmed; Matthew C Kiernan
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

4.  Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.

Authors:  Ruojie He; Minying Zheng; Ling Lian; Xiaoli Yao
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

5.  A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis.

Authors:  Emily Beswick; Deborah Forbes; Zack Hassan; Charis Wong; Judith Newton; Alan Carson; Sharon Abrahams; Siddharthan Chandran; Suvankar Pal
Journal:  J Neurol       Date:  2021-06-13       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.